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Background: China has the largest population of cataract patients in the world. However, the cataract surgery rate
per million remains low in China. We carried out a survey on costs of cataract surgery from four different graded
providers in China and analyzed differences in cost among these clinics.
Methods: 1,189 patients were recruited for the study in four eye clinics, located in two provinces, Guangdong
province in southern China and Hubei province in central China. The average cost of each cataract surgery episode
was calculated including cost of intraocular lens, cost of drugs and facility cost. We also collected information on
reimbursement and disposable annual income of local residents.
Results: Mean total cost per cataract intervention of four different providers varied considerably, ranging from US$
1,293 in Union Hospital to US$ 536 in Jingshan County Hospital. In all providers, except for Jingshan County
Hospital, the cost exceeded annual disposable income of local rural residents. As to the proportion of patients with
reimbursement, the figure for Union Hospital was only 36%, while for other three clinics it was more than 60%.
There was a significant difference between mean reimbursement ratios, with the highest ratio in Zhongshan
Ophthalmic Center being 71%.
Conclusions: Significant differences in costs of cataract surgery were found among the 4 different graded
providers. A part of the cost was borne by patients. Proportion of patients with reimbursement and mean
reimbursement ratios were higher in economically developed regions than in economically developing regions.
Much more financial support should be directed into the rural New Cooperative Medical Scheme to raise the
reimbursement ratio in rural China.
Background
Cataract is a leading cause of blindness around the
world. Approximately 18 million people worldwide are
blind from bilateral mature cataracts[1]. In developing
countries 50-90% of all blindness cases are caused by
cataracts. As the world’s largest developing country,
China is a country with nearly 1.4 billion population,
among which there are 2.5 million cataracts with an
annual increase of 400 thousand patients[2]. Removing
the cataract surgically and replacing the natural lens
with a synthetic intraocular lens (IOL) remain the only
effective treatment for cataracts. The cataract surgery
rate (CSR, the number of cataract operations performed
per million populations per year) is about 5700 in the
United States[3], but only about 4500 in India[4], and as
low as 200 in some developing countries[5,6]. However,
the CSR may vary between provinces in China, such as
1197 in Beijing, 1548 in Shanghai, 953 in Tibet, 608 in
Qinghai; but only 196 in Guizhou, 216 in Chongqing[7].
In the developing world, China and India are the two
most populous countries on earth and are at a roughly
comparable stage of economic development, while the
CSR is considerably lower in China than in India. Most
of the patients who suffer from reversible blindness due
to mature cataracts go untreated in China; as a result,
the number of blind patients is growing every year.
From a public health perspective, it is clear that senile
cataract remains a leading cause of blindness in China
and our population is experiencing a “backlog” of catar-
act. Poor services that are inaccessible, inappropriate, or
unaffordable will not be utilised and people with unoper-
ated cataract will accumulate to form a surgical backlog
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any medium, provided the original work is properly cited.[3]. To reduce the backlog, the number of cataract opera-
tions performed each year must at least equal the inci-
dence of operable cataract. A cataract screening program,
including a total of 27 screening groups, was conducted
in the rural Chaoshan area of eastern Guangdong pro-
vince between March 2008 and March 2009. Among 24
screening group subjects refusing cataract surgery, the
most common reasons were concern about costs (60.4%),
and unwillingness to undergo surgery due to age (22.9%)
[8]. Therefore, the cost of cataract surgery may be an
important factor that influences the amount of cataract
surgery[8-10].
Cataract is a common public health problem in
patients above 50 years old in China. Although the mag-
nitude of the problem is so large, little is known about
the costs of cataract surgery or variation in costs among
different providers in China. Moreover, the patterns of
cataract surgery, economic status of population and
reimbursement ratios have changed greatly in the past
few years, but little is known about the relation between
costs of surgery and disposable annual income of local
residents. Average costs incurred by cataract surgery
alone in the United Kingdom were about US$620 in
2004 dollars, but another research demonstrated that
the cost is US$3461, approximately 5.6 times of the for-
mer one. This is because of the difference between
direct and indirect costs [11]. In 2005, the mean total
costs per cataract intervention from nine European
countries(Denmark, England, France, Germany, Hun-
gary, Italy, the Netherlands, Poland, and Spain) were
€714, ranging from €318 to €1087(€1=U S $ 1 . 1 8f o r
2005)[12]. Cataract surgery is considerably less expen-
sive in Europe than in the United States with the mean
cost of surgery totaled US$2525[13,14].
In order to achieve a higher CSR, it is necessary to
investigate the barriers that may be preventing patients
from seeking surgery in China. The aim of this survey
performed in four different graded providers of China
was to collect information on costs of cataract surgery
and to compare the overall cost of surgery with disposa-
ble annual income of local residents. It is also hoped
that the survey will provide a valuable source of data for
developing new strategies for the prevention and treat-
ment of blindness caused by cataract.
Methods
Subjects with age-related cataract for this study were
recruited from four different graded providers in two
provinces (Figure 1). Zhongshan Ophthalmic Center
(ZOC) is the largest eye hospital in China, located in
Guangdong province, one of the most economic devel-
oped regions in China. The other three eye clinics from
three general hospitals are located in Hubei province in
central China. Union Hospital (UH) is located in
Wuhan, capital of Hubei province. First Hospital of
Jingzhou (FHJ) is located in Jingzhou, one medium-sized
city. Jingshan County Hospital (JCH) is located in Jian-
shan County, which is a typical agricultural county with
a total population of 640,000, 69% are farmers. These
four eye clinics represent four different size and grade
respectively in China. These clinics are described in
details in Table 1.
The average cost of a cataract extraction at each clinic
during the month of November 2009 was studied. The
cost of a cataract surgery episode including one pre-
operative visit, the surgery itself and one post-operative
visit was calculated in three sections as follows: cost of
intraocular lens, cost of drugs and facility cost. Facility
cost included laboratory test expenses, nursing expenses,
check fees, costs of equipment depreciation, and the
costs of one preoperative and one postoperative visit,
etc. The check fees included the costs of ultrasonic
examination, intraocular pressure measurement and slit
lamp examination. Operating microscopes and phacoe-
mulsifier were the main equipments used in cataract
surgery. In the case of JCH, the cost of physician and
his or her equipment charges went under facility costs.
Costs such as travel costs and costs of complications of
s u r g e r yw e r ee x c l u d e d .C o sts were based on hospital
finance department data. In addition to the costs for
one episode of cataract surgery, each provider was asked
to provide information on the reimbursement fees they
received for performing the service.
Disposable annual incomes of local urban and rural
residents were acquired from the websites of National
and Provincial Bureau of Statistics (Data from Guang-
dong province available from http://www.gdstats.gov.cn/
tjgb/t20100225_74438.htm; Hubei province available
from http://www.stats-hb.gov.cn/structure/xxgk/tjgb/
qstjgbzw_185369_1.htm; Jingzhou city available from
http://www.stats-hb.gov.cn/structure/xxgk/tjgb/
sztjgbzw_187478_1.htm; Jingshan County available from
http://www.jingshan.gov.cn/article/2010/0120/arti-
cle_8100.html; Accessed on 5 July 2010). All costs were
collected in Renminbi (RMB) and converted to US dol-
l a r s( U S $ )f r o ma ne x c h a n g er a t eo fU S $1=R M B6 . 8 .
In the study, we used the principles outlined in the
Helsinki declaration. The study was approved by the
ethical committees of Yangtze University, Huazhong
University of Science and Technology, Sun Yat-sen
University and Jingshan County.
Results
A total of 1,189 patients were recruited by 4 eye clinics:
1,038 patients from ZOC, 78 patients from UH, 45
patients from FHJ and 28 patients from JCH. Some
patients underwent bilateral surgeries, thus a total of 1,264
operations were performed in four clinics (Table 1). The
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formed in ZOC was ten times more than in the other
three hospitals. The proportion of patients from rural
areas in JCH reached 43%, while for the other three bigger
hospitals was very low. Phacoemulsification procedure was
the primary surgery used in all four hospitals and extra-
capsular cataract extraction (ECCE) was seldom used in
these hospitals. The proportion of ECCE in these clinics
was less than 2 percent. The average length of stay in
ZOC and JCH was one day, but more than one week in
UH and FHJ. Characteristics of the four clinics and catar-
act surgeries were shown in Table 1.
The average total costs for one cataract surgery epi-
sode in four clinics were 1,089 US$ (median, 973 US$;
range, 713 US$ to 2,122 US$) in ZOC, 1,293 US$ (med-
ian, 1,236 US$; range, 794 US$ to 2,345 US$) in UH,
925 US$ (median, 930 US$; range, 681 US$ to 1,170 US
$) in FHJ and 536 US$ (median, 526 US$; range, 526
US$ to 685 US$) in JCH. The costs of cataract surgery
in two provincial hospitals were twice as many as in
JCH (Figure 2). There was no qualified cataract surgeon
i nJ C H ,j u s tl i k et h em a j o r i t yo fc o u n t yh o s p i t a l si n
China. Qualified surgeons from provincial capital carried
portable phacoemulsifier to JCH to perform cataract
Figure 1 Locations of four different graded providers in two provinces of China.
Table 1 Characteristics of the four clinics and cataract surgery
Clinic ZOC UH FHJ JCH
Inhabitants in catchment area for cataract surgery 96,380,000 57,200,000 6,450,000 640,000
Number of cataract surgeries in 2009 13,348 866 510 353
Number of cataract surgeries during study month (November 2009) 1,102 82 46 28
Number of patients 1,038 78 45 28
Median age of patients(y) 71 66 69 67
Male (%) 47% 43% 52% 54%
Number of patients from rural region 126(12%) 5(6%) 5(11%) 12(43%)
Percentage of phaco-procedures during study month 99% 99% 98% 100%
Average length of stay (days) 1 8 9 1
Proportion of cases with foldable lens 100% 99% 0% 7%
Number of patients with reimbursement 766(74%) 28(36%) 30(67%) 20(71%)
Mean reimbursement ratio 71% 50% 45% 48%
Number of cataract surgeons in 2009 17 4 2 0
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consultation fee.
The different components of cataract surgery costs
identified so far are summarized in Figure 3. The mean
costs of intraocular lens in four clinics were 364 US
$(median, 289 US$; range, 273 US$ to 1,379 US$) in
ZOC, 392 US$(median, 347 US$; range, 127 US$ to 579
US$) in UH, 170 US$(median, 162 US$; range, 162 US$
to 191 US$) in FHJ and 129 US$(median, 118 US$;
range, 118 US$ to 279 US$) in JCH(Figure 4). Large dif-
ferences were found among the 4 clinics. Multi-focal
intraocular lens or adjustable intraocular lens (24/1108,
2.16%) cost more than 1,100 US$, which was only used
in ZOC. All patients in ZOC were implanted foldable
lens, but rigid lens were used in FHJ and JCH. The cost
of the cheapest lens used was 118 US$ in JCH. There
were 16 different types of lens used in ZOC, but only 2
types of lens used in FHJ and JCH.
The major part of cost was the use of antibiotics by
intravenous infusion in UH and FHJ. Cataract surgeries
in the two hospitals were performed via corneal limbal
incision, and patients had been given antibiotics once a
day after operation for 3 to 7 days aiming to prevent
infection. Then, the length of stay was one week or so.
The average cost of antibiotics for each patient was
more than 200 US$. However, a clear corneal incision
was used in ZOC and JCH, and patients stayed for one
day without intravenous infusion of drug. The main cost
for drugs in the two hospitals was the fee for eyedrops.
The number of patients with reimbursement was 766
(74%) in ZOC, 28(36%) in UH, 30(67%) in FHJ and 20
(71%) in JCH. Not all patients received reimbursement.
The patients had to pay first, and then were “reim-
bursed” by the insurance company or rural New Coop-
erative Medical Scheme (NCMS). In ZOC, the mean
reimbursement ratio (reimbursement/cost) was approxi-
mately 71%, ranging from 30% to 95%. The cost of the
surgery didn’t vary according to whether the patient had
insurance. As a part of urban residents didn’t get health
insurance and reimbursement ratio for rural residents
was quite low, a part of the cost was paid by the
patients directly.
Figure 2 Boxplots showing the average cost for each cataract
surgery episode from four different graded providers during
November 2009. Horizontal lines in each box plot represent
(bottom to top) 10th, 25th, 50th (median), 75th, and 90th
percentiles. Values above the 90th and below the 10th percentile
are plotted as stars. The abbreviations used are: ZOC, Zhongshan
Ophthalmic Center; UH, Union Hospital; FHJ, First Hospital of
Jingzhou; JCH, Jingshan County Hospital.
Figure 3 Components of cataract surgery costs in four
different graded providers. The abbreviations used are: ZOC,
Zhongshan Ophthalmic Center; UH, Union Hospital; FHJ, First
Hospital of Jingzhou; JCH, Jingshan County Hospital.
Figure 4 The average cost for intraocular lens from four
different graded providers in November 2009. Horizontal lines in
each box plot represent (bottom to top) 10th, 25th, 50th (median),
75th, and 90th percentiles. Values above the 90th and below the
10th percentile are plotted as stars. The abbreviations used are:
ZOC, Zhongshan Ophthalmic Center; UH, Union Hospital; FHJ, First
Hospital of Jingzhou; JCH, Jingshan County Hospital.
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episode with disposable annual income of local residents
in 2009(Figure 5). In Guangdong province, the Gross
Domestic Product (GDP) per capita in 2009 was
5,992US$, with disposable annual income of local urban
residents 3,173 US$ and rural residents 1,016 US$,
respectively. However in Hubei province, the disposable
annual income of local urban residents was 2,113 US$
and rural residents 740 US$, respectively. In all provi-
ders except for JCH, the cost exceeded annual disposa-
ble income of local rural residents. Proportion of
patients with reimbursement and mean reimbursement
ratios in ZOC were higher than that in three hospitals
in Hubei province, which was related with local eco-
nomic level.
Discussion
This study investigated the costs of cataract surgery
from four different graded providers in two provinces of
China and analyzed the variation in costs. The results of
this study may not be necessarily representative of
patients presenting in the other regions of China. The
mean total cost for one cataract surgery episode from
two hospitals in capital cities, ZOC and UH, was more
than 1,000 US$. The lowest cost was from JCH,
approximately 536 US$. In all providers except for JCH,
the cost was more than annual disposable income of
local rural residents. Especially in the UH, the cost was
twice as many as annual disposable income of local
rural residents.
Except the proportion of patients with reimbursement
in UH was at only 36%, the proportion in the other
three hospitals was more than 60%. There were
significant variations in reimbursement ratio from differ-
ent regions. The mean reimbursement ratio was higher
in ZOC than in three hospitals in Hubei province. The
more economy develops, the higher reimbursement
ratio is. Urban patients can be reimbursed at about
40-95% from social medical insurance. Seven years ago,
rural patients must pay the cost all by themselves[15],
but at present, more than 90% rural residents can be
reimbursed due to the attendance of NCMS. However,
the ratio of reimbursement for rural patients was
approximately 30%, which was significantly lower than
urban patients[16].
China’s economic development is characterized by
wide geographic disparities between the coastal regions
and the central/western regions. Two thirds of China’s
population, or around 900 million people, live in rural
regions that are largely under-developed and have
received few medical services. China had developed a
successful health insurance system (Cooperative Medical
Scheme, CMS) in the rural areas since the 1950s. Unfor-
tunately, CMS collapsed during the shift towards a mar-
ket economy at the end of the 1970s[17]. The New
Cooperative Medical Scheme (NCMS) is a ‘voluntary’
and heavily subsidized program established in 2003 to
reduce the risk of catastrophic health spending for rural
residents in China [15,18,19]. The scheme coverage was
95.9% in Shandong province and 88.0% in Ningxia pro-
vince in 2006[19], and 85.9% of the total rural population
by the end of 2007[16]. However, the reimbursement
ratio of the scheme was only around 30% of inpatient
expenditure.
The relatively poor economic condition in rural areas is
am a j o ri s s u ei n f l u e n c i n gt h ef e a s i b i l i t yo fp e r f o r m i n g
cataract surgeries [20]. In 2001, Helen Keller Interna-
tional (HKI) initiated free cataract testing and a low-
price, high-quality cataract surgery program in rural
areas in south China [9]. Surgery was subsidized by HKI
and priced at 66US$. A total of 80% of those surveyed
stated that they were willing to pay something for sur-
gery, but only 56% of these respondents stated a willing-
ness to pay amount of 66US$ or more. Blind subjects
were significantly more likely to pay anything for surgery,
but would pay on average 32US$. The patients suffering
from cataract were mostly older patients, and many of
them were no longer in control of their family’si n c o m e .
Compared with the rural annual income per capita, the
expensive cost for cataract surgery may be an important
contributing factor for the low CSR in rural China.
In our survey, the number of patients from rural
regions was significantly lower than that from urban
regions. Jingshan County located in central China owns
640,000 people, with approximately 440,000 people liv-
ing in rural areas. Our data showed that the cataract
surgery rate (CSR) per million in Jingshan County was
Figure 5 Comparison among disposable annual income of
local urban residents in 2009, disposable annual income of
local rural residents in 2009 and the average cost for each
cataract surgery episode in November 2009. The abbreviations
used are: ZOC, Zhongshan Ophthalmic Center; UH, Union Hospital;
FHJ, First Hospital of Jingzhou; JCH, Jingshan County Hospital.
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Therefore, there is apparent potential for an increase of
CSR in China, especially in rural areas.
A large variation in costs of intraocular lens was found
in four providers. A foldable intraocular lens (IOL) is
more expensive than an equivalent rigid IOL. In ZOC,
all patients were implanted with foldable intraocular
lens. The variation of total costs among patients mainly
came from the cost of different IOL types. Costs of
multi-focal intraocular lens or adjustable intraocular
lens were more than 1,100 US$, which were too expen-
sive to be reimbursed; thereby most patients chose sin-
gle focus intraocular lens. In three hospitals of Hubei
province, neither multifocal nor adjustable intraocular
lens was used. All four providers used imported lens.
Although there are cheaper domestic lens, none of
domestic lens was used in these hospitals because
patients thought that the quality of imported lens was
better than domestic lenses.
Under the current conditions, phacoemulsification and
small incision surgery have allowed cataract surgery to
be conducted on one-day-case basis, and then it is feasi-
ble to use eyedrops to prevent infection. A large part of
cost was spent on the usage of antibiotics by vein injec-
tion in UH and FHJ. Therefore, using antibiotic eye-
drops instead of intravenous antibiotics would decrease
20% cost of cataract intervention.
There are no qualified surgeons of cataract surgery in
Jingshan County Hospital. In China, there are around
2,200 counties like Jingshan County; and the overwhelm-
ing majority of county hospitals have neither qualified sur-
geons nor expensive equipments for phacoemulsification.
Qualified surgeons from provincial capital carried portable
phacoemulsification equipments to county hospitals and
then performed cataract surgeries once or twice a month,
which was a common health care activity. It is obvious
that the phacoemulsification procedure is more expensive
than ECCE. Manual small incision cataract surgery
(MSICS) is a modified form of ECCE performed through a
6.5 to 7.0 mm sclerocorneal tunnel [22]. As compared
with phacoemulsification, MSI C Si sa l m o s ta se f f e c t i v e
and more economical [10,23,24]. The advantages of
MSICS as a low-cost “equally effective” technique make it
an alternative, especially in rural regions in China. There
are severe shortages of skilled cataract surgeons in the
majority of county hospitals in China; thereby it is essen-
tial to train qualified surgeons for these hospitals.
Most of Chinese elderly population is rural-dwelling
and cataract is the leading cause of blindness and low
vision in this group. Approximately 66% of the cataract
operations were conducted in county hospitals with lim-
ited eye care services and 34% in specialized and provin-
cial center [20]. Because of the low benefit level and low
reimbursement ratio, patients had to face a very high
financial burden even after NCMS reimbursement[17].
Moreover, the shortage of cataract care specialists in
county hospitals is also a barrier for many patients who
need cataract surgery. Consequently, efforts should be
made to increase the financing of health care and to
train qualified surgeons for county hospitals.
Finally, the data from four different graded providers
were provided in the results, which were of potential
use to blindness prevention programs. However, there
was no a statistical point of view in our report, and the
selected four places could not fully represent the status
of other areas in China. Further work is needed to
explore the cost-effectiveness of cataract surgery in
different graded provided in China.
Conclusions
Significant differences in costs of cataract surgery were
found among the 4 different graded providers. From the
survey, several key messages should be drawn. Firstly,
patients from rural areas have many difficulties in pay-
ing for surgery cost. Much more financial support
should be directed into the rural NCMS to raise the
reimbursement ratio. Secondly, more efforts are needed
to train qualified surgeons for county hospitals. Lastly,
the usage of cheaper IOL and fewer drugs in cataract
surgery will lead to lower cost that contributes to
increase the CSR in China.
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